News

Jolanta Bernatoniene, MD, PhD, discusses data showing oral berotralstat significantly reduces moderate and severe attacks in children with hereditary angioedema.

The approval marks the first FDA-authorized treatment for allergic fungal rhinosinusitis, with trial data showing significant improvements in outcome measures.

From 2010 to 2022, urban hospitals expanded access to advanced neonatal services while rural communities experienced a net loss.

A study found cannabis use among adolescents aged 13 to 17 years was associated with a 2-fold increased risk of psychotic and bipolar disorders.

Although early introduction of allergenic foods remains a key strategy for preventing food allergies, rising infant emergency department visits may reflect mild, manageable reactions and uncertainty among families.

Suicide rates and attempts among Black youth have surged over the past decade, highlighting critical risk factors and the need for proactive screening and community-based prevention strategies.

New research highlights the fluctuating course of pediatric ADHD and the continued role of stimulant medications as first-line therapy.

A study highlights prior self-harm, traumatic brain injury, family instability, and social vulnerability as major risk factors associated with suicide among Black youth.

The gadopiclenol extension for use in infants and neonates offers high-quality MRI contrast enhancement at half the standard gadolinium dose.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Children with Crohn disease had reduced microbial diversity and increased pro-inflammatory bacteria vs peers with disorders of brain-gut interaction.

Economic instability, food insecurity, discrimination, and low social support were associated with increased odds of pediatric long COVID.

Pediatricians decode the new dietary guidelines—more protein, zero added sugar under aged 11 years, full-fat dairy—plus what’s missing for kids’ health.

A study found that pediatric patients meeting burn center referral criteria were more likely to receive specialized care.

Findings demonstrate high completion rates and overall acceptability of the EQ-5D-Y-5L in routine outpatient pediatric specialty care.

New research shows widespread generative AI use among children and teens, prompting questions about potential impacts on social, mental, and sexual development.

Influenza antiviral treatment declined significantly among hospitalized children after COVID-19, highlighting gaps in guideline-recommended care.

Phase 3 KEPLER data showed vedolizumab achieved remission in nearly half of children with ulcerative colitis, with consistent safety and durable benefit.

Trial data indicate that clesrovimab has a safety profile comparable to palivizumab and maintained protection against RSV-related infections.

A national poll finds few parents have their teens evaluated for heart disease, while gaps in training highlight ongoing challenges in responding to sudden cardiac arrest.

Nontargeted analysis identified 42 PFAS in cord blood, revealing broader prenatal exposure than traditional testing methods capture.

New international pediatric HAE guideline recommends oral sebetralstat as first-line acute therapy for adolescents 12 years and older.

A study found that 30 mg/kg/d methylprednisolone combined with tocilizumab was linked to improved neurological outcomes for encephalopathy.

A study found that rural birth hospitals experienced a net loss in higher-level neonatal services from 2010 to 2022, widening disparities with urban facilities.

FDA expands pitolisant indication to include cataplexy in patients 6 years and older with narcolepsy.

Ferric maltol gains FDA approval for children 10 years and older with iron deficiency, supported by phase 3 pediatric data.

New research demonstrates that targeted early intervention services improve academic performance and long-term health for children with developmental disabilities.

Meghan Drastal, MSN, MBA, RN, CPN, outlines CHLA’s data-driven strategies to improve workplace safety and pediatric de-escalation.